<DOC>
	<DOCNO>NCT00157820</DOCNO>
	<brief_summary>The Dual Chamber &amp; Atrial Tachyarrhythmias Adverse Events Study ( DATAS ) design analyze ability dual chamber ICDs , reduce clinically significant adverse event compare single chamber ICD non select population conventional indication ICD implantation .</brief_summary>
	<brief_title>DATAS : The Dual Chamber &amp; Atrial Tachyarrhythmias Adverse Events Study</brief_title>
	<detailed_description>Single chamber ( SC ) implantable cardioverter defibrillator ( ICDs ) several limitation might relevant follow , like atrial pacing requirement , inadequate therapy , sustain atrial tachyarrhythmias difficulty achieve accurate diagnosis arrhythmia . Dual chamber ( DC ) ICDs offer attractive rationale solution , although controversy remain cost complexity implant offer real clinical advantage . The DATAS , prospective , multicentre , randomize , open label study , three arm ( two cross-over third parallel two ) The primary objective trial determine whether use Dual Chamber ICD ( DDED-DDDR NASPE/BPEG Defibrillator/Pacemaker Codes ) result significant decrease number primary end point . The primary end point composite comprise four so-denominated `` Clinically Significant Adverse Events ( CSAE ) '' : 1. all-cause mortality 2. invasive intervention , hospitalization ( &gt; 24 h ) prolongation hospitalization due cardiovascular cause 3. inappropriate shock ( two episode inappropriate shock ) 4. sustain symptomatic atrial tachyarrhythmias ( ) require urgent termination ( b ) last 48 h lead therapeutic intervention . Secondary objective : 1 . Number component CSAE . 2 . Arrhythmia relate : atrial tachyarrhythmia ( AT ) , frequency burden , ventricular tachyarrhythmia frequency burden number appropriate shock , number inappropriate shock , need reprogramming , need medication/Radiofrequency Ablation ( RFA ) arrhythmia control , pacemaker syndrome development dual chamber pace indication . 3 . Cardiovascular relate : New York Health Association ( NYHA ) functional class , exercise capacity , leave ventricular ejection fraction ( LVEF ) , reduction medication ( diuretics. ) . 4 . Quality life : evaluate SF-36 , Minnesota live test , heart failure Symptom Checklist instrument .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>Meet Class I implantation criterion single chamber implantable cardioverter defibrillator accord guideline ( ACC/AHA ) . Permanent atrial fibrillation Patients without structural heart disease Patient meet implantation criterion dualchamber pace ( symptomatic sinus node disease , 2nd AtrioVentricular ( AV ) block [ except asymptomatic Mobitz I ] 3rd degree AV block ) . Patient previous system implant ( ICD pacemaker ) . Patients biventricular stimulation resynchronization . Patient mechanical right heart valve . Patient medical condition would preclude test require protocol , limit study participation . Patient unwilling unable cooperate give write informed consent , patient minor legal guardian refuse give informed consent . Patient inaccessible followup study center . Patients enrol plan enroll clinical trial clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Defibrillators , Implantable</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Ventricular Tachyarrhythmias</keyword>
	<keyword>Clinical Trial</keyword>
</DOC>